Charles A. Deignan, Chief Financial Officer at Clearside Biomedical, Inc. (CLSD), sold 2 shares at $7.00 ($14) on 2016-06-07, disclosed to the SEC on 2016-06-07.
Open-market sale of $14 CLSD by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CLSD | SELL | 2022-01-20 | $18K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $18K | — | Filing → |
| CLSD | SELL | 2021-06-23 | $13K | — | Filing → |